Sorry about the capitals here, a big red night in the study with music remixes can get to you. The concurrent phase 2 is now a wonderful thing and if we replicate the results, or better them as dermatitis infers with a longer treatment, then we are talking life changing. But that is down the track. I would like to hear some news about the antibacterial side of things.
Keep the faith folks.
Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-70
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 160000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 11013 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
